Role of inflammatory signaling pathways involving the CD40–CD40L–TRAF cascade in diabetes and hypertension—insights from animal and human studies
Basic Research in Cardiology · 30.03.2024 · 119 (4) · 1-18
DOI: 10.1007/s00395-024-01045-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic Research in Cardiology, online erschienen am 30.03.2024. Verfasst von Lea Strohm und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany. Hauptthemen laut MEDLINE: Signal Transduction, CD40 Ligand, Hypertension, CD40 Antigens. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Else Kröner-Fresenius-Stiftung, Deutsches Zentrum für Herz-Kreislaufforschung, European Cooperation in Science and Technology.
Themen: Diabetes mellitus
Abstract (Originalsprache)
CD40L–CD40–TRAF signaling plays a role in atherosclerosis progression and affects the pathogenesis of coronary heart disease (CHD). We tested the hypothesis that CD40L–CD40–TRAF signaling is a potential therapeutic target in hyperlipidemia, diabetes, and hypertension. In mouse models of hyperlipidemia plus diabetes (db/db mice) or hypertension (1 mg/kg/d angiotensin-II for 7 days), TRAF6 inhibitor treatment (2.5 mg/kg/d for 7 or 14 days) normalized markers of oxidative stress and inflammation. As diabetes and hypertension are important comorbidities aggravating CHD, we explored whether the CD40L–CD40–TRAF signaling cascade and their associated inflammatory pathways are expressed in CHD patients suffering from comorbidities. Therefore, we analyzed vascular bypass material (aorta or internal mammary artery) and plasma from patients with CHD with diabetes and/or hypertension. Our Olink targeted plasma proteomic analysis using the IMMUNO-ONCOLOGY panel revealed a pattern of step-wise increase for 13/92 markers of low-grade inflammation with significant changes. CD40L or CD40 significantly correlated with 38 or 56 other inflammatory targets. In addition, specific gene clusters that correlate with the comorbidities were identified in isolated aortic mRNA of CHD patients through RNA-sequencing. These signaling clusters comprised CD40L–CD40–TRAF, immune system, hemostasis, muscle contraction, metabolism of lipids, developmental biology, and apoptosis. Finally, immunological analysis revealed key markers correlated with comorbidities in CHD patients, such as CD40L, NOX2, CD68, and 3-nitrotyrosine. These data indicate that comorbidities increase inflammatory pathways in CHD, and targeting these pathways will be beneficial in reducing cardiovascular events in CHD patients with comorbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
- Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany. daiber@uni-mainz.de.
- German Center for Cardiovascular Research (DZHK), Partnersite Rhine-Main, Mainz, Germany. daiber@uni-mainz.de.
- Universitätsmedizin der Johannes Gutenberg-Universität Zentrum für Kardiologie 1, Labor für Molekulare Kardiologie, Geb. 605, Raum 3.262, Langenbeckstr. 1, 55131, Mainz, Germany. daiber@uni-mainz.de.
- Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
- German Center for Cardiovascular Research (DZHK), Partnersite Rhine-Main, Mainz, Germany.
ORCID-Profile: Andreas Daiber
Förderung
- Else Kröner-Fresenius-Stiftung
- Deutsches Zentrum für Herz-Kreislaufforschung
- European Cooperation in Science and Technology
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Zitieren
APA
Strohm, L., Daiber, A., Ubbens, H., Krishnankutty, R., Oelze, M., Kuntic, M., Hahad, O., Klein, V., Hoefer, I. E., von Kriegsheim, A., Kleinert, H., Atzler, D., Lurz, P., Weber, C., Wild, P. S., Münzel, T., Knosalla, C., Lutgens, E., & Daub, S. (2024). Role of inflammatory signaling pathways involving the CD40–CD40L–TRAF cascade in diabetes and hypertension—insights from animal and human studies. Basic Research in Cardiology, 119(4), 1-18. https://doi.org/10.1007/s00395-024-01045-1
Vancouver
Strohm L, Daiber A, Ubbens H, Krishnankutty R, Oelze M, Kuntic M, et al. Role of inflammatory signaling pathways involving the CD40–CD40L–TRAF cascade in diabetes and hypertension—insights from animal and human studies. Basic Research in Cardiology. 2024;119(4):1-18. doi:10.1007/s00395-024-01045-1
BibTeX
@article{Strohm2024,
author = {Strohm, Lea and Daiber, Andreas and Ubbens, Henning and Krishnankutty, Roopesh and Oelze, Matthias and Kuntic, Marin and Hahad, Omar and Klein, Veronique and Hoefer, Imo E and von Kriegsheim, Alex and Kleinert, Hartmut and Atzler, Dorothee and Lurz, Philipp and Weber, Christian and Wild, Philipp S and Münzel, Thomas and Knosalla, Christoph and Lutgens, Esther and Daub, Steffen},
title = {Role of inflammatory signaling pathways involving the CD40–CD40L–TRAF cascade in diabetes and hypertension—insights from animal and human studies},
journal = {Basic Research in Cardiology},
year = {2024},
volume = {119},
number = {4},
pages = {1--18},
doi = {10.1007/s00395-024-01045-1}
}
EUVIMED